IMF Asian Myeloma Network (AMN) Holds Groundbreaking Events in 2021 Read more about IMF Asian Myeloma Network (AMN) Holds Groundbreaking Events in 2021 Add new comment
Cancer Drug Parity Act Update—Patients Must Have Access to Oral Cancer Therapies Read more about Cancer Drug Parity Act Update—Patients Must Have Access to Oral Cancer TherapiesAdd new comment
With Over 30 Million Reached Across 46 Countries, the International Myeloma Foundation (IMF) Makes a Global Impact for 2022 Myeloma Action Month Read more about With Over 30 Million Reached Across 46 Countries, the International Myeloma Foundation (IMF) Makes a Global Impact for 2022 Myeloma Action Month Add new comment
U.S. FDA Approves CARVYKTI™ (ciltacabtagene autoleucel), Janssen’s First Cell Therapy, a BCMA-Directed CAR-T Immunotherapy for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma Read more about U.S. FDA Approves CARVYKTI™ (ciltacabtagene autoleucel), Janssen’s First Cell Therapy, a BCMA-Directed CAR-T Immunotherapy for the Treatment of Patients with Relapsed or Refractory Multiple MyelomaAdd new comment
International Myeloma Foundation (IMF) Launches MYeloma ACTION Campaign for Myeloma Action Month in March 2022 Read more about International Myeloma Foundation (IMF) Launches MYeloma ACTION Campaign for Myeloma Action Month in March 2022Add new comment
Janssen Submits Biologics License Application to FDA Seeking Approval of Teclistamab for the Treatment of Relapsed or Refractory Multiple Myeloma Patients Read more about Janssen Submits Biologics License Application to FDA Seeking Approval of Teclistamab for the Treatment of Relapsed or Refractory Multiple Myeloma Patients Add new comment
GMAN Meets at the 2021 American Society of Hematology (ASH) Meeting Read more about GMAN Meets at the 2021 American Society of Hematology (ASH) MeetingAdd new comment
International Myeloma Foundation Names Yelak Biru as CEO Read more about International Myeloma Foundation Names Yelak Biru as CEOAdd new comment
Four Oral Presentations from the International Myeloma Foundation-Supported iStopMM Study to Take Center Stage at 2021 ASH Annual Meeting Read more about Four Oral Presentations from the International Myeloma Foundation-Supported iStopMM Study to Take Center Stage at 2021 ASH Annual MeetingAdd new comment
International Myeloma Foundation Launches Atlanta-Area Initiative to Raise Awareness, Encourage Earlier Diagnoses in the African-American Community Read more about International Myeloma Foundation Launches Atlanta-Area Initiative to Raise Awareness, Encourage Earlier Diagnoses in the African-American Community Add new comment
